LOL and $2 dollars longer than that, tell me is the PPS closer to 2¢ or $2 dollars!!!

LOL ELTP will see sub-penny.

There will be no proof/link that Nasrat promised no Efficacy trial. He has always stated he didn't think they would be required but he also stated he might and if the FDA asked for one Elite would provide one. Pesky facts.

oh, here is the promise from Nasrat:

"As I have stated before, we have set in motion several initiatives that will have significant impact on Elite’s future,” commented Nasrat Hakim, Elite’s President and CEO. “Following the success of the pilot bioequivalence study in December for ELI-201, we are delighted with the results of this pivotal bioequivalence clinical study for ELI-200, our second opioid abuse deterrent product. ELI-200 is expected to be filed this year and will be the first NDA product filed by Elite with the U.S. Food and Drug Administration.”

actually I could not care less if you are convinced, my job here is to state the FACTS

Lol yeah he said he needed it after he said he did not lol. By the way I said all throughout 2014 that it would be needed

all you have to do is look at 2014 when he promised NDA submission by the end of the year

hmmmmmm I was told that elite did not need an efficacy study.

right, nasrat said that AFTER he realized that the FDA was not going to buy the crazy notion that no efficacy trial was needed. thanks

hmmmmmm I was told that elite did not need an efficacy study.

I am not trying to convince you, good luck

we know there is a credibility gap

How about the CEO stating "the FDA cant stop us"??

many many sources, seen daily

not so ludicrous if one considers the credibility gap faced by eltp

perhaps, given the lack of trust in management that would be warranted in this case.

Question for ELITE: Where are the minutes from the FDA meeting?

My guess is that the path (out of three) that they chose didn't work. And now they are trying another one. just a guess

Information of an alleged SEC complaint against the CEO is important information for shareholders.

doubtful, the IR market is only somewhat interesting due to the number fo scripts, but the real $$$ are in the ER segment

scripts does not = $$$$$$, sorry

Yeah since over 90% of scripts are for IR. Lol. And yes we've posted proof over and over and over and over and over again. Thanks.

doubtful, the IR market is only somewhat interesting due to the number fo scripts, but the real $$$ are in the ER segment

That near $5m fee kept them going but now, in the recent fiscal year, that fee is no longer propping them up... Uh oh

Again concocted logic by saying a PROMO helped the stock rise.
Unsubstantiated and just not true.

Toldya the sleaze ball, PAID FOR penny stock PROMO would only last 2-3 days!!

YES they are.. lol

Seems you're confused by the terms REVENUE and SALES

Revenues will be off this year by at least $2-3million, so that kinda puts things in perspective

I suppose what the CEO stated at last call about Elite annualizing at about 10M annual rate is BS then!! lol

Ya mean Elite has $8.3m revenues in for 9 full months but will surpass $4.2m in the last quarter to top the $12.5m it did last year??

Gee thanks for the heads up. Cant wait to see Elites 10K

Revenues will be off this year by at least $2-3million, so that kinda puts things in perspective

revenues were $2.3 million for the quarter and $8.3 million for the nine months ended December 31, 2016 and that's compared to $2.2 million and $7.3 million for the quarter and nine months of the prior-year. That's a 6% increase for the quarter as compared to last year and a 13% increase for the year-to-date as compared to last year.

Savvy investors don't look for links, they talk to people with "boots on the ground".

No one believes he is only getting worthless shares out of this.

Pursuant to his August 2013 employment agreement, and as amended on January 12, 2016 (the “Hakim Employment Agreement”). . .The Salary is paid in shares of the Company’s Common Stock pursuant to the Company’s current procedures for paying Company executives in Stock.

Now I didn't say that but if the CEO does not seem to understand English, what else is he missing ??????????????????????

So why would Nasrat answer, "We don't have to pay ANOTHER fee." ??????????

Why would Nasrat say, We don't have to pay another fee, when he never paid a fee in the first place ???????????????????

Gee so there is no resubmission fee as claimed. Got it!!!

nasrat said it would cost Elite another $2-3m prior to resubmitting Sequest.
Sorry if the TRUTH is troubling, I understand

Does the company have to resubmit the entire application with the additional information and will the FDA have to review the entire application and you have to pay $2.3 million? No, we don't have to resubmit the entire application. We don't have to pay another fee.

How much will these additional studies cost? About $2 million to $3 million

PRove they are not being investigated. I can prove they are

Fyi, Elite is being investigated

Not all Elite insiders have held all their shares !!!!!!!!!!!!!!!!!!!!!!

link?[/quote

Exactly. The only link to this table leads back to this:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=130613878

There are no other links and there is no such info originating from the ELTP website either. I have been here long enough to know AJ has posted other tables and charts on the message board in the past. In fact one of his tables regarding projected SequestOx revenues was posted as part of the ELTP IHub intro for awhile. Again, the info posted in the table are his estimates and projections. . .not Elites.

Even Elite doesnt expect Sequest FDA approval until the June-Aug 2019 time period!! lol